Journal article
Cost-utility analysis of telephone-based cognitive behavior therapy in chronic obstructive pulmonary disease (COPD) patients with anxiety and depression comorbidities: an application for willingness to accept concept
F Moayeri, D Dunt, YS Hsueh, C Doyle
Expert Review of Pharmacoeconomics and Outcomes Research | TAYLOR & FRANCIS LTD | Published : 2019
Abstract
Background: This study evaluated the cost-utility of telephone-based cognitive behavioral therapy (TB-CBT) (experimental arm) in comparison with a placebo-befriending (control arm) program in COPD participants with mild to severe depression and/or anxiety. Methods: The decision rule was based on willingness-to-pay if there is an increased unit of effectiveness (a quality-adjusted life year [QALY] gain) and an increase in cost, and willingness-to-accept (WTA) if there is a reduced unit of effectiveness (a QALY loss) and decrease in cost (a cost-saving). Results: TB-CBT group was associated with a reduction in the incremental cost of AUS−$407.3 (p < 0.001, SE:34.1) plus a negative, nonsign..
View full abstractRelated Projects (1)
Grants
Awarded by University of Melbourne
Funding Acknowledgements
Financial support for this study was provided entirely by Beyondblue (Project 304/11) and was undertaken with assistance from the National Ageing Research Institute (NARI). The funding agreement ensured the authors' independence in designing the study, interpreting the data, writing, and publishing the report. The correspondence author received PhD scholarship fund from University of Melbourne Faculty of Medicine, Dentistry and Health Sciences. Clinical trials identifier: ACTRN12612000254897. Available at www.anzctr.org.au/ACTRN12612000254897.aspx.